The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists

NYT Business Friday 04 September 2026, 22:44 UTC By Gina Kolata 1 min read

Key Points

An illustration of lipoprotein(a), a low-density lipoprotein. Every study short of a randomized clinical trial had indicated that the drug would lower Lp(a) and help protect people from heart disease.

The Heart Drug Pelacarsen Fails (ORG) Novartis (ORG)

Originally published by NYT Business Read original →

How to see what's taking up space on your Windows PC Use a methodical approach to see what’s using the most space on your PC and easily clean it up. There's so much competing for the space on your computer that it's easy to lose track of it all. Programs, photos, videos, games, downloads and your other items live alongside system data like temporary files and updates.

Engadget 48m ago

After 8 years, Europe's BepiColombo mission is on final approach to Mercury

The BepiColombo mission cleared a major milestone this week in the final stretch of an eight-year interplanetary voyage to Mercury, the hard-to-reach, scorching hot iron world at the Solar System's innermost frontier. The robotic science mission, with a price tag of nearly $2 billion, is led by the European Space Agency with contributions from Japan and the United States. Since its launch in 2018, BepiColombo has spiraled closer to the Sun using a combination of plasma propulsion and a...

Ars Technica 59m ago